Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L H Baker

Showing results (151-160 of 168) with videos related to

Pageof 17
Sort By:
Cancer|November 15, 1983
Treatment of six cases of mesothelioma with doxorubicin and cisplatinB L Zidar, R P Pugh, L M Schiffer, et al.
Cancer|November 1, 1984
Response of chronic myelogenous leukemia patients to COAP-splenectomy. A Southwest Oncology Group studyJ P Hester, C C Waddell, C A Coltman, et al.
Cytometry|November 1, 1993
Development and optimization of tissue preparative methodology for DNA content analysis of soft tissue neoplasmsM M Zalupski, J R Ryan, J F Ensley, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Second-line treatment of advanced measurable ovarian cancer with iproplatin: a Southwest Oncology Group studyG Weiss, S Green, D S Alberts, et al.
Investigational New Drugs|January 1, 1996
Phase I trial of Adozelesin using the treatment schedule of daily x5 every 3 weeksB J Foster, P M LoRusso, E Poplin, et al.
Cancer Treatment Reports|January 1, 1980
Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomasB S Yap, L H Baker, J G Sinkovics, et al.
Cancer|December 1, 1972
Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamideJ A Gottlieb, L H Baker, J M Quagliana, et al.
Journal of the National Cancer Institute|July 3, 1991
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group studyM Zalupski, B Metch, S Balcerzak, et al.
Gynecologic Oncology|January 1, 1989
Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stage III, optimal disease ovarian cancer: a Southwest Oncology Group StudyD S Alberts, N Mason-Liddil, R V O'Toole, et al.
Gynecologic Oncology|January 1, 1989
Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stages III and IV suboptimal disease ovarian cancer: a Southwest Oncology Group StudyD S Alberts, N Mason-Liddil, R V O'Toole, et al.
Pageof 17

Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Cancer|November 15, 1983
Treatment of six cases of mesothelioma with doxorubicin and cisplatinB L Zidar, R P Pugh, L M Schiffer, et al.
Cancer|November 1, 1984
Response of chronic myelogenous leukemia patients to COAP-splenectomy. A Southwest Oncology Group studyJ P Hester, C C Waddell, C A Coltman, et al.
Cytometry|November 1, 1993
Development and optimization of tissue preparative methodology for DNA content analysis of soft tissue neoplasmsM M Zalupski, J R Ryan, J F Ensley, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Second-line treatment of advanced measurable ovarian cancer with iproplatin: a Southwest Oncology Group studyG Weiss, S Green, D S Alberts, et al.
Investigational New Drugs|January 1, 1996
Phase I trial of Adozelesin using the treatment schedule of daily x5 every 3 weeksB J Foster, P M LoRusso, E Poplin, et al.
Cancer Treatment Reports|January 1, 1980
Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomasB S Yap, L H Baker, J G Sinkovics, et al.
Cancer|December 1, 1972
Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamideJ A Gottlieb, L H Baker, J M Quagliana, et al.
Journal of the National Cancer Institute|July 3, 1991
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group studyM Zalupski, B Metch, S Balcerzak, et al.
Gynecologic Oncology|January 1, 1989
Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stage III, optimal disease ovarian cancer: a Southwest Oncology Group StudyD S Alberts, N Mason-Liddil, R V O'Toole, et al.
Gynecologic Oncology|January 1, 1989
Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stages III and IV suboptimal disease ovarian cancer: a Southwest Oncology Group StudyD S Alberts, N Mason-Liddil, R V O'Toole, et al.
Pageof 17